EVQLV and Libera Bio announced today a collaboration agreement to jointly develop and deliver new antibodies to high-value intracellular cancer targets.
More information:
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Recent Comments